Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2017

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2017
ENANTA PHARM (NASDAQ: ENTA) Delayed: 13.37 +0.71 (5.61%)
Previous Close $12.66    52 Week High $34.49 
Open $12.85    52 Week Low $20.39 
Day High $13.40    P/E N/A 
Day Low $12.65    EPS $-3.18 
Volume 225,467